Teamit will attend the International Society for Pharmacoepidemiology (ISPE) 2026 Annual Meeting, one of the leading international events dedicated to advancing pharmacoepidemiology, drug safety and real-world evidence research.
ISPE 2026, taking place from 29 August – 2 September at the Allianz Convention Centre in Milan, brings together researchers, regulators, healthcare professionals and industry representatives from across the globe, providing a valuable forum for scientific exchange and collaboration.
Supporting collaboration through VAC4EU
This year, for the fifth year running, Teamit’s participation will combine scientific engagement with business development activities through VAC4EU – a collaborative research network for vaccine benefit and risk monitoring across Europe. Alongside Founder and CEO Eva Molero (VAC4EU Executive Board member), Teamit’s Head of Health Data Fabio Riefolo and Project and Business Development Managers Alba Ortega Flores and Alfonsina Milito will represent VAC4EU’s Business Development team. The group will welcome visitors to the VAC4EU booth (#107) to learn more about the network’s capabilities, ongoing initiatives and opportunities for collaboration.
Showcasing ongoing research
Teamit’s is also contributing to the conference programme through nine co-authored poster and lightning presentations on ongoing research and current studies, focused on our work supporting European and Global RWE initiatives.
SAFETY-VAC (Poster Session B Tue 1 Sep 11:30-13:00)
- Immunocompromised Status Definition in Observational Studies using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm
Teamit co-authors: Fabio Riefolo, Irene Pazos, Carlos Durán
- Identifying Flares of 10 Autoimmune Diseases in Electronic Healthcare Data: Operational Algorithms and Background Incidence Rates from 10 Pan-European data sources
Teamit co-authors: Fabio Riefolo (presenting), Irene Pazos, Carlos Durán
- Assessing the Impact of different data prompts on the identification of ulcerative colitis patients, time to cohort entry and occurrence of flares in four European healthcare data sources: the Component Algorithm Strategy
Teamit co-authors: Fabio Riefolo, Irene Pazos, Carlos Durán
ADEPT (Spotlight Poster Tue 1 Sep 11:30-13:00)
- The utilisation of antiseizure medications in pregnant women, and women and men of childbearing potential (ADEPT): a multi-database study from 6 European countries
Teamit co-authors: Carlos Durán, Anna Bonaterra, Fabio Riefolo, Elena Palà
Pfizer 1026 – RSV Maternal (Poster Session B Tue 1 Sep 11:30-13:00)
- Maternal ABRYSVO vaccination in the VAC4EU European network: National recommendations and early uptake patterns
Teamit co-authors: Anna Bonaterra, Elena Palà
Pfizer 1038 (Poster Session C Wed 2 Sep 12:00-13:30)
- Natural History and Clinical Outcomes of Myocarditis and Pericarditis Following Pfizer-BioNTech COVID-19 Vaccine (Comirnaty): A Multi-Database European Post-Authorisation Safety Study (PASS) in the VAC4EU network
Teamit co-authors: Elena Palà, Irene Pazos, Anna Brutau
Pfizer 1021 (Lightning Presentation Tue 1 Sep Space 3 08:20-08:25)
- Results From The Vaccine Monitoring Collaboration For Europe (VAC4EU) Post-Authorisation Safety Study For The Pfizer-BioNTech COVID-19 Vaccine (Comirnaty®) In Europe
Teamit co-authors: Irene Pazos, Elena Palà
Pfizer 1038 (Lightning Presentation Mon 31 Aug Space 3 10:30-10:35)
- Validation of Algorithms for the Identification of Myocarditis and Pericarditis in Real-World Data to Evaluate the Safety of the Pfizer-BioNTech COVID-19 Vaccine (COMIRNATY): A Post-authorisation Safety Study in the VAC4EU Network
Teamit co-authors: Elena Palà, Irene Pazos, Anna Brutau
Pfizer 1052 (Lightning Presentation Tue 1 Sep Space 3 08:30-08:35)
- Interim Results From Post-Authorisation Safety Study (PASS) for The Pfizer-BioNTechCOVID-19 Vaccine (Comirnaty)Bivalent/Omicron BA.1 and BA.4-5in Europe: A Study in the VAC4EUNetwork
Teamit co-authors: Elena Palà, Irene Pazos
Meet us at ISPE 2026
We look forward to connecting with colleagues, collaborators and new partners throughout the conference. If you are attending ISPE 2026, visit VAC4EU at booth #107 to discover how the network is contributing to the generation of high-quality real-world evidence in vaccines and pharmacoepidemiology.
Learn more about Teamit’s Health Data unit and their role in RWE studies.
About ISPE 2026
Organised by the International Society for Pharmacoepidemiology, ISPE’s Annual Meeting is the leading global event in the RWE ecosystem. The programme features a broad range of sessions, presentations and networking opportunities focused on RWD methodological innovation, data quality, and the evolving RWE landscape. Discover more about the event here.
About VAC4EU
VAC4EU is a pan-European research network for collaborative post-authorisation vaccine safety and benefit monitoring with 29 members and access to data sources covering over 185M individuals across Europe in 9 countries. Learn more about VAC4EU here.
